Alzheimer's disease drug development pipeline: 2017
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease | Nature
Mechanism of amyloid-β (Aβ) removal via Aβ-specific antibodies. FcR =... | Download Scientific Diagram
Of Four Aβ Antibodies, Only Aducanumab Stems Tide of Toxic Oligomers | ALZFORUM
S-1
Immunotherapy for Alzheimer's Disease Shows Promise | The Scientist Magazine®
IJMS | Free Full-Text | Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease | HTML
MRZ-99030 – A novel modulator of Aβ ...
A vaccine against Alzheimer`s disease: anything left but faith?
Alzheimer's disease drug development pipeline: 2018 - ScienceDirect
The amyloid cascade and Alzheimer's disease therapeutics: theory versus observation | Laboratory Investigation
Treatment of Alzheimer's Disease and Blood–Brain Barrier Drug Delivery
Aβ-Immunotherapeutic strategies: a wide range of approaches for Alzheimer's disease treatment | Expert Reviews in Molecular Medicine | Cambridge Core
S-1/A
PDF) Aducanumab. Anti-beta-amyloid monoclonal antibody, Treatment of Alzheimer's disease
Dysregulation of Intracellular Calcium Signaling in Alzheimer's Disease. - Abstract - Europe PMC
Solanezumab Overview - Creative Biolabs
Aducanumab - an overview | ScienceDirect Topics
Prospects for strain-specific immunotherapy in Alzheimer's disease and tauopathies | npj Vaccines
IJMS | Free Full-Text | Drug Development for Alzheimer's Disease: Microglia Induced Neuroinflammation as a Target? | HTML
תרופה חדשה לחולי דמנציה ואלצהיימר: התרופה בדרך לאישור Aducanumab for Alzheimer's
Anti-Amyloid-β Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise - Biological Psychiatry
Developing Effective Alzheimer's Disease Therapies: Clinical Experience and Future Directions - IOS Press
THERAPEUTIC FOCUS - The Future of Treating Alzheimer's Disease: Aducanumab & Beyond
Current and emerging avenues for Alzheimer's disease drug targets - Loera‐Valencia - 2019 - Journal of Internal Medicine - Wiley Online Library
The Importance of Early Identification of Alzheimer's Disease
Frontiers | Interplay Between Mitochondrial Oxidative Disorders and Proteostasis in Alzheimer's Disease | Neuroscience
